Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.22 AUD | +1.99% | +5.36% | -18.98% |
Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Sales 2024 * | 154M 101M | Sales 2025 * | 174M 115M | Capitalization | 2.53B 1.67B |
---|---|---|---|---|---|
Net income 2024 * | 92M 60.7M | Net income 2025 * | 96M 63.34M | EV / Sales 2024 * | 14.9 x |
Net cash position 2024 * | 236M 156M | Net cash position 2025 * | 344M 227M | EV / Sales 2025 * | 12.6 x |
P/E ratio 2024 * |
27.3
x | P/E ratio 2025 * |
26.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.53% |
Latest transcript on Neuren Pharmaceuticals Limited
1 day | +2.07% | ||
1 week | +5.36% | ||
Current month | +5.36% | ||
1 month | -2.74% | ||
3 months | -11.70% | ||
6 months | +58.67% | ||
Current year | -18.98% |
Managers | Title | Age | Since |
---|---|---|---|
Jon Pilcher
CEO | Chief Executive Officer | 58 | 13-08-18 |
Lauren Frazer
DFI | Director of Finance/CFO | - | 20-07-31 |
Liza Squires
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 02-03-04 | |
Dianne Angus
BRD | Director/Board Member | 63 | 18-07-04 |
Jenny Lee Harry
BRD | Director/Board Member | - | 18-07-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +3.34% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 20.22 | +1.99% | 241 599 |
24-05-06 | 19.82 | +0.61% | 353,695 |
24-05-03 | 19.7 | +2.71% | 288,623 |
24-05-02 | 19.18 | +0.63% | 304,316 |
24-05-01 | 19.06 | -0.73% | 442,875 |
Delayed Quote Australian S.E., May 07, 2024 at 01:52 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.98% | 1.68B | |
+31.52% | 690B | |
+21.96% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.68% | 235B | |
+3.81% | 199B | |
-10.63% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- NEU Stock